from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1501/-

LFCtreatmentdescriptionclass of inhibitor

-0.796

Amikacinug/mL Amikacintranslation

-0.955

Cap5-10ug/mL Capreomycintranslation

-1.432

Rox10-50 ug/mL Roxithromycintranslation

0.044

SM2-5 ug/mL Streptomycintranslation

-1.575

Tet5-10 ug/mL Tetracyclinetranslation

-0.796

Rif0.2-5ug/mL Rifampicintranscription

0.581

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.219

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.031

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.487

CPZ10-50 ug/mL Chlorpromazinerespiration

1.769

Clofazimine10-13 ug/mL Clofaziminerespiration

0.855

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.517

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.123

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.700

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.980

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.998

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.313

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.060

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.261

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.792

KCN5-20 ug/mL Potassium cyaniderespiration

0.489

NaN30.2-2 mM Sodium aziderespiration

-0.766

Nigericin50 uM Nigericinrespiration

-0.014

TRC10-150 ug/mL Triclosanrespiration

-0.870

TRZ10-25 ug/mL Thioridazinerespiration

-0.991

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.967

menadione6-10 ug/mL Menadionerespiration

0.325

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.413

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.021

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.791

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.579

NRP_1Non-replicating persistence stage 1dosRassociated

0.385

Amp0.2mg/mL AmpicillincellWall

0.854

Cephalexin20-100 ug/mL CephalexincellWall

0.558

Cerulenin0.32-5 ug/mL CerulenincellWall

0.138

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.136

EMB10-20 ug/mL EthambutolcellWall

0.534

Eta12-40 ug/mL EthionamidecellWall

0.502

INH0.2-0.4 ug/mL IsoniazidcellWall

0.272

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.888

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.513

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.479

BZA0.12 mg/mL BenzamidearomaticAmides

-0.174

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.021

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.954

H2O24 mM hydrogen peroxideDNAdamaging

0.226

Levo10 ug/mL LevofloxacinDNAdamaging

-0.236

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.764

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.002

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.427

UVUV-irradiationDNAdamaging

0.422

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.128

Antimycin12.5-50 ug/mL Antimycin A?

-0.704

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.030

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.126

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.141

PA8240.2-2 ug/mL PA-824?

0.233

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.309

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.516

Verapamil50 uM Verapamil?

-0.095

mercaptoethanol2 mM 2-Mercaptoethanol?

0.142

methoxatin10-20 ug/mL Methoxatin?